CN114315595B - Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst - Google Patents
Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst Download PDFInfo
- Publication number
- CN114315595B CN114315595B CN202111439912.5A CN202111439912A CN114315595B CN 114315595 B CN114315595 B CN 114315595B CN 202111439912 A CN202111439912 A CN 202111439912A CN 114315595 B CN114315595 B CN 114315595B
- Authority
- CN
- China
- Prior art keywords
- reaction
- catalyst
- ethanol
- iron
- based catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 158
- 239000003054 catalyst Substances 0.000 title claims abstract description 142
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 230000015572 biosynthetic process Effects 0.000 title abstract description 7
- 238000003786 synthesis reaction Methods 0.000 title abstract description 7
- 230000001093 anti-cancer Effects 0.000 title abstract description 4
- 239000003112 inhibitor Substances 0.000 title abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 332
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 7
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims abstract description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 229
- 150000005181 nitrobenzenes Chemical class 0.000 claims description 46
- 125000001153 fluoro group Chemical group F* 0.000 claims description 16
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 14
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 14
- 229910052794 bromium Inorganic materials 0.000 claims description 14
- 150000004031 phenylhydrazines Chemical class 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 229940044631 ferric chloride hexahydrate Drugs 0.000 claims description 2
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 abstract description 63
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 4
- 239000001257 hydrogen Substances 0.000 abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 3
- 125000000524 functional group Chemical group 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000000967 suction filtration Methods 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 112
- 239000007787 solid Substances 0.000 description 53
- 239000000203 mixture Substances 0.000 description 52
- 150000001448 anilines Chemical class 0.000 description 35
- 238000001994 activation Methods 0.000 description 33
- 230000004913 activation Effects 0.000 description 33
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 15
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 12
- 125000001309 chloro group Chemical group Cl* 0.000 description 12
- -1 amino compound Chemical class 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 8
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229940041181 antineoplastic drug Drugs 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 238000001308 synthesis method Methods 0.000 description 5
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 150000002828 nitro derivatives Chemical class 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- QMQXDJATSGGYDR-UHFFFAOYSA-N methylidyneiron Chemical compound [C].[Fe] QMQXDJATSGGYDR-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- GIBAIULVBOBDED-UHFFFAOYSA-N 1-(4-aminophenyl)cyclopentane-1-carbonitrile Chemical compound C1=CC(N)=CC=C1C1(C#N)CCCC1 GIBAIULVBOBDED-UHFFFAOYSA-N 0.000 description 1
- ANLABNUUYWRCRP-UHFFFAOYSA-N 1-(4-nitrophenyl)cyclopentane-1-carbonitrile Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1(C#N)CCCC1 ANLABNUUYWRCRP-UHFFFAOYSA-N 0.000 description 1
- FSOKYBXZZFFPAS-UHFFFAOYSA-N 1-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]cyclohexa-3,5-diene-1,2,4-triamine Chemical compound CN(CCC1(C(C=C(C(=C1)OC)NC1=NC=CC(=N1)C1=CN(C2=CC=CC=C12)C)N)NC)C FSOKYBXZZFFPAS-UHFFFAOYSA-N 0.000 description 1
- ZCBIFHNDZBSCEP-UHFFFAOYSA-N 1H-indol-5-amine Chemical compound NC1=CC=C2NC=CC2=C1 ZCBIFHNDZBSCEP-UHFFFAOYSA-N 0.000 description 1
- WTFWZOSMUGZKNZ-UHFFFAOYSA-N 1H-indol-7-amine Chemical compound NC1=CC=CC2=C1NC=C2 WTFWZOSMUGZKNZ-UHFFFAOYSA-N 0.000 description 1
- DSPAUOALMSIBJA-UHFFFAOYSA-N 2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzonitrile Chemical compound COC1=CC(N)=C(C#N)C=C1OCCCN1CCOCC1 DSPAUOALMSIBJA-UHFFFAOYSA-N 0.000 description 1
- YQADLKDQAXAIKW-UHFFFAOYSA-N 2-amino-5-bromopyridin-3-ol Chemical compound NC1=NC=C(Br)C=C1O YQADLKDQAXAIKW-UHFFFAOYSA-N 0.000 description 1
- SFTHVDYRPHJAND-UHFFFAOYSA-N 2-chloro-1-[(3-fluorophenyl)methoxy]-4-nitrobenzene Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1OCC1=CC=CC(F)=C1 SFTHVDYRPHJAND-UHFFFAOYSA-N 0.000 description 1
- JHARVUVBTAAPLA-UHFFFAOYSA-N 2-chloro-4-methyl-3-nitropyridine Chemical compound CC1=CC=NC(Cl)=C1[N+]([O-])=O JHARVUVBTAAPLA-UHFFFAOYSA-N 0.000 description 1
- UOBCYTOUXLAABU-UHFFFAOYSA-N 2-chloro-4-methylpyridin-3-amine Chemical compound CC1=CC=NC(Cl)=C1N UOBCYTOUXLAABU-UHFFFAOYSA-N 0.000 description 1
- LBPCMDALPLHBTE-UHFFFAOYSA-N 3-fluoro-5-nitropyridine Chemical compound [O-][N+](=O)C1=CN=CC(F)=C1 LBPCMDALPLHBTE-UHFFFAOYSA-N 0.000 description 1
- WFRXSXUDWCVSPI-UHFFFAOYSA-N 3h-benzimidazol-5-amine Chemical compound NC1=CC=C2NC=NC2=C1 WFRXSXUDWCVSPI-UHFFFAOYSA-N 0.000 description 1
- FGDOUMVPHJHSCK-UHFFFAOYSA-N 4-(2-methyl-4-nitro-5-propan-2-yloxyphenyl)pyridine Chemical compound C1=C([N+]([O-])=O)C(OC(C)C)=CC(C=2C=CN=CC=2)=C1C FGDOUMVPHJHSCK-UHFFFAOYSA-N 0.000 description 1
- LUNUNJFSHKSXGQ-UHFFFAOYSA-N 4-Aminoindole Chemical compound NC1=CC=CC2=C1C=CN2 LUNUNJFSHKSXGQ-UHFFFAOYSA-N 0.000 description 1
- XGCRDQKFYXFXHA-UHFFFAOYSA-N 4-fluoro-6-methoxy-1-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,3-diamine Chemical compound FC1=C(C=C(C(=C1)OC)NC1=NC=CC(=N1)C1=CN(C2=CC=CC=C12)C)N XGCRDQKFYXFXHA-UHFFFAOYSA-N 0.000 description 1
- FYCDMKYKGPHRFW-UHFFFAOYSA-N 4-methoxy-5-(3-morpholin-4-ylpropoxy)-2-nitrobenzonitrile Chemical compound COC1=CC([N+]([O-])=O)=C(C#N)C=C1OCCCN1CCOCC1 FYCDMKYKGPHRFW-UHFFFAOYSA-N 0.000 description 1
- QGAIPGVQJVGBIA-UHFFFAOYSA-N 4-methyl-3-n-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine Chemical compound CC1=CC=C(N)C=C1NC1=NC=CC(C=2C=NC=CC=2)=N1 QGAIPGVQJVGBIA-UHFFFAOYSA-N 0.000 description 1
- BIQABKFYKJRXII-NSHDSACASA-N 4-n-(3-chloro-4-fluorophenyl)-7-[(3s)-oxolan-3-yl]oxyquinazoline-4,6-diamine Chemical compound N1=CN=C2C=C(O[C@@H]3COCC3)C(N)=CC2=C1NC1=CC=C(F)C(Cl)=C1 BIQABKFYKJRXII-NSHDSACASA-N 0.000 description 1
- QRZFUQFQXCRJRR-UHFFFAOYSA-N 4-n-(3-chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine Chemical compound C=12C=C(N)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 QRZFUQFQXCRJRR-UHFFFAOYSA-N 0.000 description 1
- LAVZKLJDKGRZJG-UHFFFAOYSA-N 4-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=CC2=C1C=CN2 LAVZKLJDKGRZJG-UHFFFAOYSA-N 0.000 description 1
- OOPJQYJTWRBGME-UHFFFAOYSA-N 5-bromo-2-nitropyridin-3-ol Chemical compound OC1=CC(Br)=CN=C1[N+]([O-])=O OOPJQYJTWRBGME-UHFFFAOYSA-N 0.000 description 1
- ZRORIJXOWXYPMO-UHFFFAOYSA-N 5-fluoropyridin-3-amine Chemical compound NC1=CN=CC(F)=C1 ZRORIJXOWXYPMO-UHFFFAOYSA-N 0.000 description 1
- LJZJXRBNKBWOSN-UHFFFAOYSA-N 5-methyl-2-propan-2-yloxy-4-pyridin-4-ylaniline Chemical compound CC=1C(=CC(=C(N)C=1)OC(C)C)C1=CC=NC=C1 LJZJXRBNKBWOSN-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- XPAZGLFMMUODDK-UHFFFAOYSA-N 6-nitro-1h-benzimidazole Chemical compound [O-][N+](=O)C1=CC=C2N=CNC2=C1 XPAZGLFMMUODDK-UHFFFAOYSA-N 0.000 description 1
- AHRUOBCIEORMLN-UHFFFAOYSA-N 7-chloro-8-nitroquinoline Chemical compound C1=CN=C2C([N+](=O)[O-])=C(Cl)C=CC2=C1 AHRUOBCIEORMLN-UHFFFAOYSA-N 0.000 description 1
- KXIVDGBOGABQHA-UHFFFAOYSA-N 7-chloroquinolin-8-amine Chemical compound C1=CN=C2C(N)=C(Cl)C=CC2=C1 KXIVDGBOGABQHA-UHFFFAOYSA-N 0.000 description 1
- LZJGQIVWUKFTRD-UHFFFAOYSA-N 7-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=CC2=C1NC=C2 LZJGQIVWUKFTRD-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QRJWUPUPBUPXQE-UHFFFAOYSA-N CNC1(C=C(C(=CC1[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C)OC)CCN(C)C Chemical compound CNC1(C=C(C(=CC1[N+](=O)[O-])NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C)OC)CCN(C)C QRJWUPUPBUPXQE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 1
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
- 239000002136 L01XE07 - Lapatinib Substances 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- ULXXDDBFHOBEHA-CWDCEQMOSA-N afatinib Chemical compound N1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC1=CC=C(F)C(Cl)=C1 ULXXDDBFHOBEHA-CWDCEQMOSA-N 0.000 description 1
- 229960001686 afatinib Drugs 0.000 description 1
- 229960003982 apatinib Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000007036 catalytic synthesis reaction Methods 0.000 description 1
- 229960001602 ceritinib Drugs 0.000 description 1
- WRXDGGCKOUEOPW-UHFFFAOYSA-N ceritinib Chemical compound CC=1C=C(NC=2N=C(NC=3C(=CC=CC=3)NS(=O)(=O)C(C)C)C(Cl)=CN=2)C(OC(C)C)=CC=1C1CCNCC1 WRXDGGCKOUEOPW-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960004887 ferric hydroxide Drugs 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 229960002584 gefitinib Drugs 0.000 description 1
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
- 229960002411 imatinib Drugs 0.000 description 1
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 description 1
- 229960004891 lapatinib Drugs 0.000 description 1
- BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- UXAZURVGMXJLSO-NSHDSACASA-N n-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3s)-oxolan-3-yl]oxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(O[C@@H]3COCC3)C([N+](=O)[O-])=CC2=C1NC1=CC=C(F)C(Cl)=C1 UXAZURVGMXJLSO-NSHDSACASA-N 0.000 description 1
- VKEKKVCWODTGAP-UHFFFAOYSA-N n-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine Chemical compound C=12C=C([N+]([O-])=O)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 VKEKKVCWODTGAP-UHFFFAOYSA-N 0.000 description 1
- SZTYQQYYIMVETL-UHFFFAOYSA-N n-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine Chemical compound COC1=CC(F)=C([N+]([O-])=O)C=C1NC1=NC=CC(C=2C3=CC=CC=C3N(C)C=2)=N1 SZTYQQYYIMVETL-UHFFFAOYSA-N 0.000 description 1
- WPEWQEMJFLWMLV-UHFFFAOYSA-N n-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide Chemical compound C=1C=CN=C(NCC=2C=CN=CC=2)C=1C(=O)NC(C=C1)=CC=C1C1(C#N)CCCC1 WPEWQEMJFLWMLV-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- NXQKSXLFSAEQCZ-SFHVURJKSA-N sotorasib Chemical compound FC1=CC2=C(N(C(N=C2N2[C@H](CN(CC2)C(C=C)=O)C)=O)C=2C(=NC=CC=2C)C(C)C)N=C1C1=C(C=CC=C1O)F NXQKSXLFSAEQCZ-SFHVURJKSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
- C07B43/04—Formation or introduction of functional groups containing nitrogen of amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
- C07C209/32—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups
- C07C209/36—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of nitro groups by reduction of nitro groups bound to carbon atoms of six-membered aromatic rings in presence of hydrogen-containing gases and a catalyst
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
- C07C211/47—Toluidines; Homologues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/49—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
- C07C211/50—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/51—Phenylenediamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/74—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C215/76—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
- C07C217/86—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C241/02—Preparation of hydrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Abstract
The invention aims to provide a preparation method of a carbon-supported iron-based catalyst and application of an anticancer inhibitor intermediate thereof in synthesis. According to the method, the prepared monoatomic iron-based carbon doped material is used as a catalyst, hydrazine hydrate is used as a hydrogen source, and the key intermediate is synthesized by reacting in solvents such as methanol, ethanol, isopropanol and the like under mild conditions with high yield. The method has the following advantages: the high-purity target product can be obtained only by suction filtration and washing, the solvent can be recycled, and the catalyst can be reused for ten times after being washed, dried and activated by the solvent. The preparation method of the catalyst has the advantages of simple process, environment friendliness, high efficiency, low cost, good functional group compatibility and simple post-treatment, and has potential value of industrial production.
Description
[ field of technology ]
The invention relates to a novel synthesis method of an iron-based carbon supported catalyst and application thereof in synthesis of an anticancer drug intermediate, belonging to the field of medicine catalytic synthesis. The catalyst has simple preparation process and mild condition, and the catalyst is used in reducing nitro group as intermediate of anticancer medicine into amino compound.
[ background Art ]
Amino compounds are important fine chemical intermediates, and can be widely applied to the fields of pesticides, organic functional materials, medicines and the like. The main method for synthesizing the organic amine compound is to reduce the nitro compound into amino compound, and the most widely used method at present is to reduce the nitro compound into amine compound: iron and hydrazine. For example: iron, calcium chloride and hydrazine systems, ferric trichloride and hydrazine systems, ferric hydroxide oxide, polymer and hydrazine systems, nano-ferric oxide and hydrazine systems, and iron carbon doped and hydrazine systems. The above method for nitroreduction has many problems, a large amount of byproduct iron black is produced, the post-treatment is complex, the yield is low, the reaction time is long, the tolerance of functional groups is poor, the environmental pollution is large, and the preparation of the catalyst is complex. In addition, palladium carbon hydrogenation reduction, the reaction process needs a specially-made high-pressure resistant reaction kettle, has high equipment requirements and has great potential safety hazard. Iron is an element which is green, environment-friendly, cheap and necessary for human body, and is one of the metal elements with highest content on the earth. Based on the background, a large amount of literature researches prove that the novel synthesis method of the iron-based carbon-supported single-atom catalyst is prepared, the preparation process of the catalyst is simple, the condition is mild, the catalyst is applied to the synthesis of a plurality of key anticancer drug intermediates, and the method adopts cheap and easily available industrial charcoal as a catalyst raw material. Research shows that the catalyst can reduce nitro compound into amine compound in high yield, and the catalyst may be reused ten times after being re-activated through simple filtering and solvent washing, and the catalyst has high catalytic activity. At present, no published literature and patent application about a single-atom catalyst for iron-doped carbon nitration reduction exist at home and abroad.
[ invention ]
The invention aims to provide a novel preparation method of an iron and carbon supported catalyst, which is applied to the synthesis of key intermediates of anticancer drugs such as the anticancer drugs of octreotide, gefitinib, afatinib, imatinib, AMG510, dacatinib, ceritinib, lapatinib, apatinib and the like. The synthesis method takes the iron-based carbon negative material prepared by us as a catalyst, takes hydrazine hydrate as a hydrogen source, and synthesizes a key intermediate in high yield through mild reaction in solvents such as methanol, ethanol, isopropanol and the like. The target product is obtained by simple filtration, solvent washing and high purity recovery of the solvent, and the catalyst can be reused for ten times after solvent washing, drying and activation. The method is characterized in that: the synthesized iron-based carbon carrier is used as a catalyst, the nitrobenzene derivative I is used as a reaction raw material, the reaction is effectively carried out in an alcohol solvent at 60-100 ℃, and the aminobenzene derivative II can be obtained within 2-8 h.
Wherein said R is 1 、R 2 、R 3 、R 4 、R 5 Is a functional group such as hydrogen, hydroxyl, fluorine, chlorine, bromine, methyl, ethyl, cyano, hydroxyl, amide, tert-butyl, phenyl, etc.
In the synthesis method, the dosage of the iron catalyst is 0.1 equivalent, and the alcohol is a solvent; the reaction time is 2-8h, and the reaction temperature is-25 ℃ to 85 ℃.
The synthesis method for reducing nitro-synthetic ammonia compounds by using the iron-carbon doped single-atom catalyst opens up a new low-cost green path, and has the advantages that: the yield of the target product is high, the reaction condition is mild, and the reaction operation is simple.
[ description of the drawings ]
Fig. 1 is a route diagram of the carbon-supported iron-based catalyst prepared by the invention applied to synthesis of a key anticancer drug intermediate, fig. 2 is an EDXmapping imaging diagram of the carbon-supported iron-based catalyst, and fig. 3 is an AC-TEM imaging diagram of the carbon-supported iron-based catalyst.
[ detailed description ] of the invention
According to the invention, ferric chloride hexahydrate (270 g,1 mol) is dissolved in 1000-2000ml of water, activated carbon (1200 g,10 mol) is added, the temperature is raised to 60-100 ℃, 50% sodium hydroxide solution (160-200 g,4-5 mol) is slowly added dropwise, stirring is carried out for 1-5h at 60-100 ℃, stirring and cooling are carried out to room temperature, stirring is carried out overnight, filtering is carried out, and washing is carried out. And drying at 60-400 ℃ for 12-24 hours to obtain 1300g of carbon-supported iron-based catalyst. Then 0.1mol of the iron-based supported catalyst is added into 1mol of nitrobenzene derivative, dissolved in 2-3L of alcohol solution, and reacted for 2-8 hours at the temperature of 60-100 ℃ to obtain the target aniline compound. The invention is further illustrated below in connection with specific preparations:
example 1:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 =ethyl, R 1 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 =ethyl, R 1 =R 3 =R 4 =R 5 ) The yield is 98%, the purity is more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 2:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 ,R 3 Methyl, R 1 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 ,R 3 Methyl, R 1 =R 4 =R 5 =h), yield 95%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 3:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 Methyl, R 2 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 Methyl, R 2 =R 3 =R 4 =R 5 =h), yield 96%, purity greater than 99%, catalyst 80-200 ℃ dryActivated overnight and reused. Example 4:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 =chloro, R 4 Methyl, R 2 =R 3 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 =chloro, R 4 Methyl, R 2 =R 3 =R 5 =h), yield 90%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 5:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 =fluoro, R 2 Methyl, R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 =fluoro, R 2 Methyl, R 3 =R 4 =R 5 =h), yield 91%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 6:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 =chloro, R 2 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 =chloro, R 2 =R 3 =R 4 =R 5 =h), yield 93%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 7:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 3 =chloro, R 1 =R 2 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 3 =chloro, R 1 =R 2 =R 4 =R 5 =h), yield 95%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 8:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 =fluoro, R 1 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 =fluoro, R 1 =R 3 =R 4 =R 5 =h), yield 94%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 9:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 =bromine, R 2 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 =bromine, R 2 =R 3 =R 4 =R 5 =h), yield 87%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 10:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 3 =bromine, R 1 =R 2 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, hot filtering, washing with ethanol, and recovering solvent to obtain white solid aniline derivativeBiological II (R) 3 =bromine, R 1 =R 2 =R 4 =R 5 =h), yield 86%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 11:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 =bromine, R 4 =trifluoromethyl, R 1 =R 3 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 =bromine, R 4 =trifluoromethyl, R 1 =R 3 =R 5 =h), yield 86%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 12:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 Methyl, R 3 =fluoro, R 2 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 Methyl, R 3 =fluoro, R 2 =R 4 =R 5 =h), yield 46%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 13:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 3 Amino group, R 1 =R 2 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 3 Amino group, R 1 =R 2 =R 4 =R 5 =h), yield 91%, purity greater than 99%, catalyst 80-200 ℃ dried overnightActivating and reusing.
Example 14:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 Amino group, R 1 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 Amino group, R 1 =R 3 =R 4 =R 5 =h), yield 91%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 15:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 Ethyl alcohol, R 1 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 Ethyl alcohol, R 1 =R 3 =R 4 =R 5 =h), yield 80%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 16:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 1 =hydroxy, R 2 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 1 =hydroxy, R 2 =R 3 =R 4 =R 5 =h), yield 93%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 17:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 3 =amide, R 1 =R 2 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 3 =amide, R 1 =R 2 =R 4 =R 5 =h), yield 93%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 18:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 2 Methyl formate, R 1 =R 3 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 2 Methyl formate, R 1 =R 3 =R 4 =R 5 =h), yield 96%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 19:
nitrobenzene derivative I (R) was charged into a 5L reaction flask 3 Acetylene group, R 1 =R 2 =R 4 =R 5 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative II (R) 3 Acetylene group, R 1 =R 2 =R 4 =R 5 =h), yield 90%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 20:
1mol of nitrobenzene derivative 3-nitro-5-fluoropyridine and 0.1mol of iron-based catalyst and 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 3-amino-5-fluoropyridine, the yield is 91 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 21:
1mol of nitrobenzene derivative 2-nitro-3-hydroxy-5-bromopyridine and 0.1mol of iron-based catalyst, 2-3L ethanol are added into a 5L reaction flask, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 2-amino-3-hydroxy-5-bromopyridine, the yield is 92%, the purity is more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 22:
1mol of nitrobenzene derivative 7-fluoro-6-nitroquinolin-2- (1H) -one and 0.1mol of iron-based catalyst, 2-3L ethanol were added to a 5L reaction flask, and the reaction was stirred at 60-70℃for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 7-fluoro-6-aminoquinoline-2- (1 hydrogen) -ketone, the yield is 81 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 23:
1mol of nitrobenzene derivative 7-chloro-8-nitroquinoline and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 7-chloro-8-aminoquinoline, the yield is 81 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 24:
1mol of nitrobenzene derivative 5-nitrobenzimidazole and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 5-aminobenzimidazole, the yield is 88 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 25:
1mol of nitrobenzene derivative 4-nitroindole and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 4-aminoindole, the yield is 89%, the purity is more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 26:
1mol of nitrobenzene derivative 5-nitroindole and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative 5-aminoindole, the yield is 88 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 27:
1mol of nitrobenzene derivative 7-nitroindole and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain the white solid aniline derivative 7-aminoindole, the yield is 86 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 28:
1mol of 2-isopropoxy-5-methyl-4- (pyridin-4-yl) nitrobenzene and 0.1mol of iron-based catalyst, 2-3L ethanol are added into a 5L reaction flask, the reaction is stirred at 60-70 ℃ for 2-8h and followed by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid 2-isopropoxy-5-methyl-4- (pyridine-4-yl) aniline, the yield is 86 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 29:
into a 5L reaction flask was charged (S) -N 4 - (3-chloro-4-fluorophenyl) -6-nitro-7- ((tetrahydrofuran-3-yl) oxy) quinazolin-4-amine 1mol and iron-based catalysisThe reaction was stirred at 60-70℃for 2-8h with 0.1mol of 2-3L ethanol and was followed by TLC until completion. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid (S) -N 4 - (3-chloro-4-fluorophenyl) -7- ((tetrahydrofuran-3-yl) oxy) quinazoline-4, 6-diamine, the yield is 86%, the purity is more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 30:
n was added to a 5L reaction flask 1 - (2- (dimethylamino) ethyl) -5-methoxy-N 1 -methyl-N 4 - (4- (1-methyl-1H-indol-3-yl) pyrimidin-2-yl) -2-nitrobenzene-1, 4-diamine 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 60-70℃for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid N 1 - (2- (dimethylamino) ethyl) -5-methoxy-N 1 -methyl-N 4 - (4- (1-methyl-1H-indol-3-yl) pyrimidine-2-yl) benzene-1, 2, 4-triamine has the yield of 92%, the purity of more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 31:
1mol of N- (4-fluoro-2-methoxy-5-nitrophenyl) -4- (1-methyl-1H-indol-3-yl) pyrimidine-2-amine and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8H, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid N- (4-fluoro-2-methoxy-5-aminophenyl) -4- (1-methyl-1H-indol-3-yl) pyrimidine-2-amine, the yield is 92 percent, the purity is more than 99 percent, and the catalyst is dried and activated at 80-200 ℃ for repeated use.
Example 32:
1mol of 4-methoxy-5- (3-morpholinopropoxy) -2-nitrobenzonitrile and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid 2-amino-4-methoxy-5- (3-morpholinopropoxy) benzonitrile, the yield is 89%, the purity is more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 33:
1mol of 1- (4-nitrophenyl) cyclopentane-1-carbonitrile and 0.1mol of iron-based catalyst, 2-3L of ethanol were added to a 5L reaction flask, and the reaction was stirred at 60-70℃for 2-8 hours and followed by TLC until completion. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid 1- (4-aminophenyl) cyclopentane-1-carbonitrile, the yield is 94 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 34:
1mol of 2-chloro-4-methyl-3-nitropyridine and 0.1mol of iron-based catalyst, 2-3L of ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid 2-chloro-4-methylpyridine-3-amine, the yield is 91 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 35:
in a 5L reaction flask was added 1mol of 2-chloro-1- ((3-fluorobenzyl) oxy) -4-nitrobenzene and 0.1mol of iron-based catalyst, 2-3L ethanol, and the reaction was stirred at 60-70℃for 2-8h and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid 2-chloro-1- ((3-fluorobenzyl) oxy) -4-aniline, the yield is 89%, the purity is more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 36:
1mol of N- (3-chloro-4-fluorophenyl) -7-methoxy-6-nitroquinazolin-4-amine and 0.1mol of iron-based catalyst, 2-3L ethanol are added into a 5L reaction bottle, the reaction is stirred at 60-70 ℃ for 2-8h, and the reaction is tracked by TLC until the reaction is complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid N- (3-chloro-4-fluorophenyl) -7-methoxy quinazoline-4, 6-diamine, the yield is 93 percent, the purity is more than 99 percent, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 37:
adding N-' into a 5L reaction bottle1mol of 2-methyl-5-nitrophenyl) -4- (pyridin-3-yl) pyrimidin-2-amine and 0.1mol of iron-based catalyst, 2-3L ethanol were reacted at 60-70℃with stirring for 2-8h and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid 6-methyl-N 1 - (4- (pyridine-3-yl) pyrimidine-2-yl) benzene-1, 3-diamine has the yield of 96%, the purity of more than 99%, and the catalyst is dried and activated overnight at 80-200 ℃ and is reused.
Example 38:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 Amino group, R 1 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 2 Amino group, R 1 =R 3 =R 4 =h), yield 94%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 39:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 =R 2 Methyl, R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 1 =R 2 Methyl, R 3 =R 4 =h), yield 96%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 40:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 Methyl, R 1 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 2 Methyl, R 1 =R 3 =R 4 =h), yield 97%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 41:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 =methoxy, R 1 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 2 =methoxy, R 1 =R 3 =R 4 =h), yield 90%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 42:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 =hydroxy, R 1 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 2 =hydroxy, R 1 =R 3 =R 4 =h), yield 89%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 43:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 =R 2 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 1 =R 2 =R 3 =R 4 =h), yield 76%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 44:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 Amino group, R 2 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 1 Amino group, R 2 =R 3 =R 4 =h), yield 93%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 45:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 =bromine, R 2 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at 75-85 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid aniline derivative IV (R) 1 =bromine, R 2 =R 3 =R 4 =h), yield 95%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 46:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 =chloro, R 1 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 2 =chloro, R 1 =R 3 =R 4 =h), yield 96%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 47:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 =fluoro, R 2 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 1 =fluoro, R 2 =R 3 =R 4 =h), yield 96%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 48:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 Cyano, R 2 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 1 Cyano, R 2 =R 3 =R 4 =h), yield 90%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 49:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 =chloro, R 4 =fluoro, R 1 =R 3 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 2 =chloro, R 4 =fluoro, R 1 =R 3 =h), yield 91%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 50:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 =fluoro, R 2 =chloro, R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 1 =fluoro, R 2 =chloro, R 3 =R 4 =h), yield 89%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 51:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 =bromine, R 4 =fluorine,R 1 =R 3 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 2 =bromine, R 4 =fluoro, R 1 =R 3 =h), yield 89%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
Example 52:
A5L reaction flask was charged with nitrobenzene derivative III (R 2 =bromine, R 1 =R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 2 =bromine, R 1 =R 3 =R 4 =h), yield 92%, purity greater than 99%, catalyst 80-200 ℃ dried overnight for activation, and repeated use.
Example 53:
A5L reaction flask was charged with nitrobenzene derivative III (R 1 =R 2 =fluoro, R 3 =R 4 =h) 1mol and iron-based catalyst 0.1mol,2-3L ethanol, the reaction was stirred at-25 ℃ to 25 ℃ for 2-8H and followed by TLC until the reaction was complete. After the reaction is finished, the mixture is filtered by heat, washed by ethanol and the solvent is recovered to obtain white solid phenylhydrazine derivative V (R) 1 =R 2 =fluoro, R 3 =R 4 =h), yield 93%, purity greater than 99%, catalyst dried overnight at 80-200 ℃ for activation, and repeated use.
The foregoing examples illustrate only a few embodiments of the invention and are described in detail herein without thereby limiting the scope of the invention. It should be noted that it will be apparent to those skilled in the art that several variations and modifications can be made without departing from the spirit of the invention, which are all within the scope of the invention. Accordingly, the scope of protection of the present invention is to be determined by the appended claims.
Claims (2)
1. The application of the carbon-supported iron-based catalyst in preparing phenylhydrazine derivative V is characterized in that the carbon-supported iron-based catalyst is prepared by the following preparation method:
dissolving 270g of ferric chloride hexahydrate and 1mol in 1000-2000ml of water, adding 1200g of active carbon and 10mol, heating to 60-100 ℃, slowly dripping 160-200g of 50% sodium hydroxide solution and 4-5mol, stirring for 1-5h at 60-100 ℃, stirring and cooling to room temperature, stirring overnight, filtering and washing, drying at 60-400 ℃ for 12-24h to obtain 1300g of carbon-supported iron-based catalyst,
the method for preparing phenylhydrazine derivative V comprises the following steps: adding 0.1mol of the carbon-supported iron-based catalyst into 1mol of nitrobenzene derivative III, dissolving in 2-3L of alcohol solution, and reacting for 2-8 hours in the presence of hydrazine hydrate at the temperature of minus 25-25 ℃ to obtain phenylhydrazine derivative V, wherein the reaction formula is as follows:
wherein said R is 1 、R 2 、R 3 、R 4 Each independently is fluorine, chlorine, bromine, cyano.
2. The use of the carbon-supported iron-based catalyst according to claim 1 for the preparation of phenylhydrazine derivatives V, wherein the carbon-supported iron-based catalyst is reusable.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111439912.5A CN114315595B (en) | 2021-11-30 | 2021-11-30 | Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst |
PCT/CN2022/134453 WO2023098592A1 (en) | 2021-11-30 | 2022-11-25 | Preparation method for carbon-loaded iron-based catalyst and use thereof in synthesis of intermediates of anti-cancer inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111439912.5A CN114315595B (en) | 2021-11-30 | 2021-11-30 | Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114315595A CN114315595A (en) | 2022-04-12 |
CN114315595B true CN114315595B (en) | 2023-12-05 |
Family
ID=81048612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111439912.5A Active CN114315595B (en) | 2021-11-30 | 2021-11-30 | Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114315595B (en) |
WO (1) | WO2023098592A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240055046A (en) * | 2021-09-02 | 2024-04-26 | 신톤 비.브이. | How to Make Osimertinib |
CN114315595B (en) * | 2021-11-30 | 2023-12-05 | 奥锐特药业股份有限公司 | Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst |
CN115010700A (en) * | 2022-07-19 | 2022-09-06 | 安徽海康药业有限责任公司 | Imamine preparation method based on fixed bed catalytic process |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101701015A (en) * | 2009-11-25 | 2010-05-05 | 天津泰普药品科技发展有限公司 | Method for preparing imatinib intermediate for treating chronic granulocytic leukemia |
CN105399737A (en) * | 2014-09-10 | 2016-03-16 | 四川好医生药业集团有限公司 | Oxazolidinones compound and application thereof |
CN105693690A (en) * | 2014-11-27 | 2016-06-22 | 无锡好芳德药业有限公司 | New method for preparing imatinib intermediate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558085B (en) * | 2011-12-28 | 2014-07-02 | 湖南方盛制药股份有限公司 | Method for preparing inezolid |
CN102617358A (en) * | 2012-03-06 | 2012-08-01 | 连云港市金囤农化有限公司 | Preparation method of arylamine |
CN103086963A (en) * | 2013-01-29 | 2013-05-08 | 吉林修正药业新药开发有限公司 | Synthetic method of flupirtine maleate A-type crystal compound and midbody |
CN104327095A (en) * | 2014-09-23 | 2015-02-04 | 湖南省湘中制药有限公司 | Preparation method of thieno- benzodiaxepin acidic salt |
CN114315595B (en) * | 2021-11-30 | 2023-12-05 | 奥锐特药业股份有限公司 | Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst |
-
2021
- 2021-11-30 CN CN202111439912.5A patent/CN114315595B/en active Active
-
2022
- 2022-11-25 WO PCT/CN2022/134453 patent/WO2023098592A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101701015A (en) * | 2009-11-25 | 2010-05-05 | 天津泰普药品科技发展有限公司 | Method for preparing imatinib intermediate for treating chronic granulocytic leukemia |
CN105399737A (en) * | 2014-09-10 | 2016-03-16 | 四川好医生药业集团有限公司 | Oxazolidinones compound and application thereof |
CN105693690A (en) * | 2014-11-27 | 2016-06-22 | 无锡好芳德药业有限公司 | New method for preparing imatinib intermediate |
Non-Patent Citations (1)
Title |
---|
FeO(OH)/C 催化水合肼还原芳香族硝基化合物制备芳胺;蔡可迎;《化学世界》(第7期);第418-420、435页 * |
Also Published As
Publication number | Publication date |
---|---|
WO2023098592A1 (en) | 2023-06-08 |
CN114315595A (en) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114315595B (en) | Preparation method of carbon-supported iron-based catalyst and application of intermediate synthesis of anticancer inhibitor of carbon-supported iron-based catalyst | |
CN106883216B (en) | Preparation method of oxitinib | |
CN111978263B (en) | Preparation method of fampicin and intermediate thereof | |
CN102321076B (en) | Preparation method of lapatinib intermediate and analogues thereof | |
CN109369545B (en) | Synthesis process of 2-methyl-5-pyrazine formate | |
CN104860923A (en) | Vonoprazan fumarate preparation method | |
CN107935997B (en) | Synthesis method of Ostinib | |
CN107417478B (en) | Method for synthesizing asymmetric disubstituted urea by catalytic oxidation carbonylation | |
CN110981816B (en) | Synthesis method of 4-amino-2, 6-dimethoxypyrimidine | |
CN106008366A (en) | Preparation method of rilpivirine | |
CN101698664B (en) | Preparation method of pharmaceutical intermediate 2-amine methylpyrazine hydrochloride | |
CN101613246B (en) | Preparation method of N-substituted ethylene diamine derivative | |
CN110183377A (en) | A kind of synthetic method of anticancer drug Rui Gefeini | |
CN104974057A (en) | Preparation method and important intermediate of bromfenac sodium | |
WO2015169130A1 (en) | New vortioxetine intermediate and synthesis process thereof | |
CN110028436B (en) | Preparation method of Vonoprazan key intermediate | |
CN109970574B (en) | Preparation method of N, N-diisopropyl-1, 3-propane diamine | |
CN114605381A (en) | Preparation method of pomalidomide | |
CN105418613A (en) | Environment-friendly preparation method of adenine | |
CN106117200B (en) | Prevention or the preparation method for the treatment of joint replacement phlebothrombosis medicine Eliquis | |
WO2014097152A1 (en) | Process for the preparation of pazopanib or salts thereof | |
CN109265403A (en) | A kind of synthetic method of benzimidazole and its derivative | |
EP2935250B1 (en) | Process for the preparation of pazopanib or salts thereof | |
CN102796074B (en) | Method for preparing imatinib mesylate intermediate | |
CN112225685B (en) | 3-cyanoindole compound, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230118 Address after: 317200 eight industrial parks, Tiantai County, Zhejiang, Taizhou Applicant after: AURISCO PHARMACEUTICAL CO.,LTD. Address before: Yuelu District City, Hunan province 410082 Changsha Lushan Road No. 1 Hunan University Applicant before: HUNAN University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |